Microfluidic RNA Liposome Manufacturing for Size and Encapsulation Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for new manufacturing approaches that enable the safe, convenient, and cost-effective production of liposome-encapsulated nucleic acid on a commercially viable scale while preserving physicochemical characteristics that maintain immunological performance.
Innovation Solution
The use of a microfluidic device to manufacture a non-viral delivery system comprising a liposome encapsulating RNA, involving the mixing of a solvent and cationic lipid solution with a water and RNA solution, followed by solvent removal, utilizing a stock solution with a specific ethanol-to-water ratio and including cationic lipids like DSPC, sterols, and PEGylated lipids.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional mixing methods are used to manufacture liposome-encapsulated nucleic acid, then production can be achieved, but manufacturing precision and consistency of physicochemical characteristics deteriorate
Solution Approach 1:
The manufacturing process is segmented into distinct functional modules within the microfluidic device, including separate mixing zones, encapsulation chambers, and flow control sections. This segmentation enables precise control over each step of liposome formation and nucleic acid encapsulation, ensuring consistent physicochemical characteristics while maintaining manufacturing feasibility through modular design
Solution Approach 2:
The invention utilizes controlled changes in physical parameters including flow rates, pressure gradients, and temperature conditions within the microfluidic system. By precisely adjusting these parameters, the process achieves reproducible liposome encapsulation efficiency and size distribution, resolving the contradiction between manufacturing precision and ease of manufacture
2Manufacturing precision
If microfluidic device is used to manufacture liposome encapsulated RNA, then manufacturing precision and encapsulation efficiency improve, but device complexity increases
Solution Approach 1:
The microfluidic device is designed with multi-functionality, where a single integrated chip performs mixing, encapsulation, size control, and flow regulation functions. This universal design achieves precise liposome manufacturing while reducing overall system complexity compared to multiple separate devices, as the same microfluidic structure serves multiple manufacturing purposes
Solution Approach 2:
The microfluidic device acts as an intermediary system that translates simple input materials into precisely controlled liposome products. The device's micro-scale fluidic channels and structures serve as intermediaries between the macro-scale manufacturing inputs and the nano-scale liposome outputs, enabling precision manufacturing without requiring complex external control systems
3Manufacturing precision
If solvent removal step is included in the manufacturing process, then RNA encapsulation efficiency improves, but production time and process complexity increase
Solution Approach 1:
The manufacturing process is designed to perform preliminary encapsulation of RNA within liposomes during the microfluidic mixing phase, achieving high encapsulation efficiency before the solvent removal step. This preliminary action reduces the burden on subsequent processing steps and minimizes overall production time while maintaining high RNA encapsulation efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method produces liposomes with controlled size and high RNA encapsulation efficiency, enhancing biological activity and immune response through efficient delivery to various cell types.
Implementation Method 1
mixing in the device a first solution comprising a solvent and a cationic lipid; and a second solution comprising water and the RNA
Implementation Method 2
removing the solvent
Data Source
AI summary
Methods for manufacturing a non-viral delivery system comprising a liposome encapsulating an RNA using a microfluidic device and compositions for use therein are provided.